BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/11/2019 1:08:54 AM | Browse: 779 | Download: 782
 |
Received |
|
2018-11-14 04:06 |
|
Peer-Review Started |
|
2018-11-14 09:28 |
|
To Make the First Decision |
|
2018-11-28 05:59 |
|
Return for Revision |
|
2018-12-05 03:06 |
|
Revised |
|
2019-01-11 18:23 |
|
Second Decision |
|
2019-01-16 09:02 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2019-01-22 04:42 |
|
Articles in Press |
|
2019-01-22 04:42 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-03-01 10:12 |
|
Publish the Manuscript Online |
|
2019-03-11 01:08 |
| ISSN |
2220-3168 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Minireviews |
| Article Title |
Achieving control of resistant hypertension: Not just the number of blood pressure medications
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Kara Schmidt, William Kelley, Steven Tringali and Jian Huang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jian Huang, FACP, MD, Attending Doctor, Professor, Department of Internal Medicine, University of California San Francisco-Fresno Medical Education Program, 2615 E Clinton Ave, Fresno, CA 93703, United States. jian.huang@va.gov |
| Key Words |
Resistant hypertension; Pseudoresistance; Mineralocorticoid receptor antagonists; Device-based hypertension treatment; Renal denervation; Carotid baroreceptor activation therapy; Central arteriovenous anastomosis |
| Core Tip |
Resistant hypertension (RH) is associated with an increased risk of cardiovascular events as well as mortality. Updated American College of Cardiology and American Heart Association guidelines in 2017 promote the use of mineralocorticoid receptor antagonists, which is a major change from prior guidelines. Device-based therapies such as renal denervation and carotid baroreceptor activation have emerged as innovative treatment modalities. They are continuing to be refined to improve their safety as well as efficacy profiles. Overall more validation is needed for device-based therapies, especially in the RH population. |
| Publish Date |
2019-03-11 01:08 |
| Citation |
Schmidt K, Kelley W, Tringali S, Huang J. Achieving control of resistant hypertension: Not just the number of blood pressure medications. World J Hypertens 2019; 9(1): 1-16 |
| URL |
https://www.wjgnet.com/2220-3168/full/v9/i1/1.htm |
| DOI |
https://dx.doi.org/10.5494/wjh.v9.i1.1 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
